Vasomedical, Inc. (VASO) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	437K
Depreciation and amortization of property and equipment	1.58M
Amortization of deferred gain on sale-leaseback of building
Provision for doubtful accounts	96K
Amortization of deferred distributor costs
Share-based compensation
Amortization of deferred consulting expense
Accounts and other receivables	2.21M
Inventories, net	-374K
Finance receivables
Deferred commission expense	448K
Other current assets	-422K
Other assets	-285K
Accounts payable	74K
Accrued commissions
Accrued expenses and other liabilities	-488K
Sales tax payable	-27K
Deferred revenue	-100K
Accrued rent expense
Accrued professional fees
Trade payable due to related party
Other long-term liabilities	38K
Net cash used in operating activities
Purchases of property and equipment	-1.41M
Purchases of short-term investments	0
Net cash used in investing activities
Proceeds from preferred stock
Net cash provided by financing activities
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	3.54M
Cash and cash equivalents - beginning of period	2.16M
Cash and cash equivalents - end of period	5.7M
Interest paid	589K
Income taxes paid	474K
Inventories transferred to property and equipment, attributable to operating leases, net
Conversion of notes payable to preferred stock
Accrued preferred stock dividends

Entities mentioned with VASO

View All Entities